Balancing risks versus benefits in drug therapy decisions

被引：5

作者：

Lasagna, L ^{[1
]}

机构：

[1] Tufts Ctr Study Drug Dev, Boston, MA 02111 USA

来源：

CLINICAL THERAPEUTICS | 1998年 / 20卷

关键词：

adverse reactions; drug regulation; drug benefits; individualized therapy;

D O I：

10.1016/S0149-2918(98)80010-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The regulation of foods and drugs in the United States has repeatedly been increased in response to unjustified marketing claims or instances of dramatic harm from these substances. Because drugs are never safe or effective for everyone? the guiding principle for physicians should be to use pharmaceuticals in such a way as to maximize benefit and minimize harm.

引用

页码：C72 / C79

页数：8

共 7 条

[1] DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE [J].